Business Description
Boai NKY Medical Holdings Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100000SV3
Share Class Description:
SZSE:300109: Class ACompare
Compare
Traded in other countries / regions
300109.China IPO Date
2010-08-25Description
Boai NKY Medical Holdings Ltd is engaged in Research and development, production of pharmaceutical excipients, APIs (povidone-iodine), adhesives, food additives (insoluble polyvinyl polypyrrolidone); polyvinyl pyrrolidone series products, vinyl methyl ether/maleic anhydride polymers.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.79 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | 0.94 | |||||
| Interest Coverage | 182.28 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 5.95 | |||||
| Beneish M-Score | -2.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.7 | |||||
| 3-Year EBITDA Growth Rate | 56.1 | |||||
| 3-Year EPS without NRI Growth Rate | 166.2 | |||||
| 3-Year FCF Growth Rate | -13.5 | |||||
| 3-Year Book Growth Rate | 4.9 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.02 | |||||
| 9-Day RSI | 25.15 | |||||
| 14-Day RSI | 33.87 | |||||
| 6-1 Month Momentum % | 57.08 | |||||
| 12-1 Month Momentum % | 63.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.12 | |||||
| Quick Ratio | 1.55 | |||||
| Cash Ratio | 0.52 | |||||
| Days Inventory | 154.21 | |||||
| Days Sales Outstanding | 92.55 | |||||
| Days Payable | 128.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 7.44 | |||||
| Dividend Payout Ratio | 1.2 | |||||
| 3-Year Dividend Growth Rate | 191.2 | |||||
| Forward Dividend Yield % | 7.44 | |||||
| 5-Year Yield-on-Cost % | 56.23 | |||||
| Shareholder Yield % | 4.44 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50.42 | |||||
| Operating Margin % | 30.96 | |||||
| Net Margin % | 26.84 | |||||
| FCF Margin % | 8.41 | |||||
| ROE % | 11.32 | |||||
| ROA % | 9.59 | |||||
| ROIC % | 12.31 | |||||
| 3-Year ROIIC % | -76.72 | |||||
| ROC (Joel Greenblatt) % | 25.05 | |||||
| ROCE % | 11.85 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.9 | |||||
| PE Ratio without NRI | 16.09 | |||||
| Shiller PE Ratio | 31.95 | |||||
| Price-to-Owner-Earnings | 32.57 | |||||
| PEG Ratio | 0.79 | |||||
| PS Ratio | 4.48 | |||||
| PB Ratio | 1.86 | |||||
| Price-to-Tangible-Book | 2.15 | |||||
| Price-to-Free-Cash-Flow | 55.23 | |||||
| Price-to-Operating-Cash-Flow | 15.92 | |||||
| EV-to-EBIT | 15.33 | |||||
| EV-to-EBITDA | 15.33 | |||||
| EV-to-Revenue | 4.43 | |||||
| EV-to-FCF | 52.63 | |||||
| Price-to-Projected-FCF | 2.15 | |||||
| Price-to-DCF (Earnings Based) | 1.16 | |||||
| Price-to-DCF (FCF Based) | 4.79 | |||||
| Price-to-Median-PS-Value | 0.78 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.64 | |||||
| Price-to-Graham-Number | 1.24 | |||||
| Price-to-Net-Current-Asset-Value | 12.9 | |||||
| Earnings Yield (Greenblatt) % | 6.52 | |||||
| FCF Yield % | 1.92 | |||||
| Forward Rate of Return (Yacktman) % | 20.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Boai NKY Medical Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,487.885 | ||
| EPS (TTM) (Â¥) | 0.794 | ||
| Beta | 1.31 | ||
| Volatility % | 44.35 | ||
| 14-Day RSI | 33.87 | ||
| 14-Day ATR (Â¥) | 0.786111 | ||
| 20-Day SMA (Â¥) | 15.6865 | ||
| 12-1 Month Momentum % | 63.02 | ||
| 52-Week Range (Â¥) | 7.711538 - 18.98 | ||
| Shares Outstanding (Mil) | 484.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Boai NKY Medical Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Boai NKY Medical Holdings Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Boai NKY Medical Holdings Ltd Frequently Asked Questions
What is Boai NKY Medical Holdings Ltd(SZSE:300109)'s stock price today?
The current price of SZSE:300109 is ¥13.42. The 52 week high of SZSE:300109 is ¥18.98 and 52 week low is ¥7.71.
When is next earnings date of Boai NKY Medical Holdings Ltd(SZSE:300109)?
The next earnings date of Boai NKY Medical Holdings Ltd(SZSE:300109) is .
Does Boai NKY Medical Holdings Ltd(SZSE:300109) pay dividends? If so, how much?
The Dividend Yield %  of Boai NKY Medical Holdings Ltd(SZSE:300109) is 7.44% (As of Today), Highest Dividend Payout Ratio of Boai NKY Medical Holdings Ltd(SZSE:300109) was 1.2. The lowest was 0.19. And the median was 0.23. The  Forward Dividend Yield % of Boai NKY Medical Holdings Ltd(SZSE:300109) is 7.44%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers